Protozoan Derived Antagonist of CCR5 Read more about Protozoan Derived Antagonist of CCR5 US Application 60/586,884Filed on 2004-07-08
Repertoire Cloning of Chimpanzee Fab Fragments and Production of Full-Length Humanized IGG1 Antibodies Efficient for Neutralization of Dengue Type 1-4 Viruses Read more about Repertoire Cloning of Chimpanzee Fab Fragments and Production of Full-Length Humanized IGG1 Antibodies Efficient for Neutralization of Dengue Type 1-4 Viruses US Application 60/552,528Filed on 2004-03-12
Method of Detecting Cancer Based On Immune Reaction To BORIS Read more about Method of Detecting Cancer Based On Immune Reaction To BORIS US Application 60/611,798Filed on 2004-09-21
Compositions And Methods For Generating An Immune Response Read more about Compositions And Methods For Generating An Immune Response US Application 60/251,083Filed on 2000-12-01
Compositions And Methods For Generating An Immune Response Read more about Compositions And Methods For Generating An Immune Response US Application 60/186,364Filed on 2000-03-02
Chondroitin Sulphate A Binding Domains Read more about Chondroitin Sulphate A Binding Domains US Application 60/615,300Filed on 2004-09-30
Glycine As A Protein Stablzer In Montanide ISA 720 Vaccine Formulation Read more about Glycine As A Protein Stablzer In Montanide ISA 720 Vaccine Formulation US Application 60/576,361Filed on 2004-06-01
Isolation And Characterization Of Chimpanzee Monoclonal Antibodies Capable Of Efficiently Neutralizing Dengue Type 1,2,3 And 4 Viruses Read more about Isolation And Characterization Of Chimpanzee Monoclonal Antibodies Capable Of Efficiently Neutralizing Dengue Type 1,2,3 And 4 Viruses US Application 60/541,676Filed on 2004-02-04
HIV Vaccine Immunogens And Immunization Strategies To Elicit Broadly Neutralizing Anti-HIV-1 Against The Membrane-Proximal Ectodomain Of HIV Gp41 Read more about HIV Vaccine Immunogens And Immunization Strategies To Elicit Broadly Neutralizing Anti-HIV-1 Against The Membrane-Proximal Ectodomain Of HIV Gp41 US Application 60/570,883Filed on 2004-05-14
Safer Attenuated Virus Vaccines With Missing or Diminished Latency of Infection Read more about Safer Attenuated Virus Vaccines With Missing or Diminished Latency of Infection US Application 60/583,399Filed on 2004-06-29